Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Shenzhen Salubris Pharmaceuticals Co Ltd
Income from Continuing Operations
Shenzhen Salubris Pharmaceuticals Co Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
|
Income from Continuing Operations
¥580.8m
|
CAGR 3-Years
126%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-4%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Income from Continuing Operations
¥3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Income from Continuing Operations
¥3.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Income from Continuing Operations
¥4.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Income from Continuing Operations
¥4.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Income from Continuing Operations
-¥780.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Shenzhen Salubris Pharmaceuticals Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
580.8m
CNY
Based on the financial report for Dec 31, 2023, Shenzhen Salubris Pharmaceuticals Co Ltd's Income from Continuing Operations amounts to 580.8m CNY.
What is Shenzhen Salubris Pharmaceuticals Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-4%
Over the last year, the Income from Continuing Operations growth was -8%. The average annual Income from Continuing Operations growth rates for Shenzhen Salubris Pharmaceuticals Co Ltd have been 126% over the past three years , -17% over the past five years , and -4% over the past ten years .